Print

Red Wine Compound Can Combat Alzheimer’s, Georgetown University Medical Center Study  
5/14/2012 7:10:23 AM

A national, phase II clinical trial examining the effects of resveratrol on individuals with mild to moderate dementia due to Alzheimer's disease has begun as more than two dozen academic institutions recruit volunteers in the coming months. R. Scott Turner, M.D., Ph.D., director of Georgetown University Medical Center's Memory Disorders Program, is the lead investigator for the national study.
//-->